The Cigna Group(CI)NASDAQ
Company Profile & Information
Company Profile
Business overview, scale, and footprint
Business Overview
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges.
The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Insider Transactions
Open-market activity and option exercises
Insider Activity Summary
Insider trading activity for The Cigna Group (CI) over the last 3 months consists of 59 total transactions. Among these, company executives and board members conducted 59 buys (totaling 835,356 shares) and 0 sells (totaling 0 shares). This activity resulted in a net change of 835,356 shares, reflecting net buying interest with an estimated net acquisitions value of $20.54M.
59 insider transactions found. Showing 10 of 59 transactions.
| Insider Name | Relation to Company | Shares Changed | Price | Transaction Date |
|---|---|---|---|---|
| KATES JAMIE G | Officer | 899 | $0.27 | Jun 12, 2026 |
| CORDANI DAVID M | Chief Executive Officer | 212,543 | $36.21 | May 13, 2026 |
| CORDANI DAVID M | Chief Executive Officer | 201,878 | $59.11 | May 12, 2026 |
| OZUAH PHILLIP | Director | 782 | $N/A | Apr 22, 2026 |
| HATHI NEESHA | Director | 782 | $N/A | Apr 22, 2026 |
| ROSS KIMBERLY A | Director | 782 | $N/A | Apr 22, 2026 |
| KURIAN GEORGE | Director | 782 | $N/A | Apr 22, 2026 |
| HENNIGAN MICHAEL J | Director | 782 | $N/A | Apr 22, 2026 |
| MCCLELLAN MARK B | Director | 782 | $N/A | Apr 22, 2026 |
| WISEMAN ERIC C | Director | 782 | $N/A | Apr 22, 2026 |